Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron?

Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.55.4352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Ramosetron Versus Palonosetron in Combination With Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Integrating Aprepitant and Palonosetron Into Clinical Practice: A Role for the New Antiemetics

Clinical Journal of Oncology Nursing
Oncology
2005English

Controversies Involving the Role of 5-Hydroxytryptamine in Generating Colonic Migrating Motor Complexes: What Is Spontaneous?

Gastroenterology
HepatologyGastroenterology
2010English

Palonosetron (Aloxi): A Second-Generation 5-Ht3 Receptor Antagonist for Chemotherapy-Induced Nausea and Vomiting

Baylor University Medical Center Proceedings
Medicine
2006English

Single Amino Acid Substitution Affects Desensitization of the 5-Hydroxytryptamine Type 3 Receptor Expressed in Xenopus Oocytes.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Every‐other‐day Palonosetron Plus Aprepitant for Prevention of Emesis Following Induction Chemotherapy for Acute Myeloid Leukemia: A Randomized, Controlled Study From the “Rete Ematologica Pugliese”

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Effects of 5-Hydroxytryptamine 2C Receptor Agonist MK212 and 2A Receptor Antagonist MDL100907 on Maternal Behavior in Postpartum Female Rats

Pharmacology Biochemistry and Behavior
PharmacologyBiochemistryClinical BiochemistryBehavioral NeuroscienceToxicologyBiological Psychiatry
2014English

Ketanserin, a Novel 5-Hydroxytryptamine Antagonist: Monotherapy in Essential Hypertension.

British Journal of Clinical Pharmacology
Pharmacology
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy